Metsera (MTSR) IPO deck
Metsera develops advanced therapies for obesity and metabolic diseases, leveraging cutting-edge peptide technologies.
Metsera develops advanced therapies for obesity and metabolic diseases, leveraging cutting-edge peptide technologies.
%20IPO%20deck){kind=link}